Frequencies for first 10,000 rows of indi_pt variable in indi2012q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 4 0.04 0.04 ABDOMINAL PAIN | 4 0.04 0.08 ABDOMINAL PAIN UPPER | 1 0.01 0.09 ABDOMINOPLASTY | 1 0.01 0.10 ABNORMAL BEHAVIOUR | 2 0.02 0.12 ABSCESS | 1 0.01 0.13 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 0.14 ACCIDENTAL EXPOSURE | 18 0.18 0.32 ACINETOBACTER INFECTION | 4 0.04 0.36 ACNE | 25 0.25 0.61 ACNE CYSTIC | 1 0.01 0.62 ACQUIRED HAEMOPHILIA | 1 0.01 0.63 ACROMEGALY | 6 0.06 0.69 ACUTE CORONARY SYNDROME | 4 0.04 0.73 ACUTE GRAFT VERSUS HOST DISEASE | 3 0.03 0.76 ACUTE LEUKAEMIA | 3 0.03 0.79 ACUTE LYMPHOCYTIC LEUKAEMIA | 16 0.16 0.95 ACUTE MYELOID LEUKAEMIA | 16 0.16 1.11 ACUTE MYELOID LEUKAEMIA (IN REMISSION) | 1 0.01 1.12 ACUTE MYOCARDIAL INFARCTION | 6 0.06 1.18 ACUTE SINUSITIS | 1 0.01 1.19 ADENOCARCINOMA | 1 0.01 1.20 ADJUSTMENT DISORDER WITH MIXED ANXIET.. | 1 0.01 1.21 ADRENAL INSUFFICIENCY | 1 0.01 1.22 ADVERSE EVENT | 3 0.03 1.25 AFFECTIVE DISORDER | 4 0.04 1.29 AGE-RELATED MACULAR DEGENERATION | 4 0.04 1.33 AGGRESSION | 2 0.02 1.35 AGITATION | 1 0.01 1.36 ALCOHOL USE | 4 0.04 1.40 ALLERGY PROPHYLAXIS | 1 0.01 1.41 ALOPECIA | 1 0.01 1.42 AMNESIA | 1 0.01 1.43 AMYLOIDOSIS | 2 0.02 1.45 ANAEMIA | 10 0.10 1.55 ANAEMIA OF CHRONIC DISEASE | 1 0.01 1.56 ANAEMIA OF MALIGNANT DISEASE | 1 0.01 1.57 ANAESTHESIA | 7 0.07 1.64 ANAL CANCER | 1 0.01 1.65 ANAL FISTULA | 1 0.01 1.66 ANALGESIC INTERVENTION SUPPORTIVE THE.. | 1 0.01 1.67 ANALGESIC THERAPY | 3 0.03 1.70 ANAPHYLACTIC REACTION | 1 0.01 1.71 ANDROGEN DEFICIENCY | 3 0.03 1.74 ANDROGEN REPLACEMENT THERAPY | 2 0.02 1.76 ANDROGENETIC ALOPECIA | 1 0.01 1.77 ANGINA PECTORIS | 9 0.09 1.86 ANGIODYSPLASIA | 1 0.01 1.87 ANGIOGRAM | 1 0.01 1.88 ANKYLOSING SPONDYLITIS | 83 0.83 2.71 ANORECTAL DISORDER | 1 0.01 2.72 ANTI-INFECTIVE THERAPY | 2 0.02 2.74 ANTIALLERGIC THERAPY | 2 0.02 2.76 ANTIBIOTIC PROPHYLAXIS | 15 0.15 2.91 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS T.. | 2 0.02 2.93 ANTIBIOTIC THERAPY | 2 0.02 2.95 ANTICOAGULANT THERAPY | 18 0.18 3.13 ANTIFUNGAL PROPHYLAXIS | 19 0.19 3.32 ANTIFUNGAL TREATMENT | 1 0.01 3.33 ANTIINFLAMMATORY THERAPY | 1 0.01 3.34 ANTIOESTROGEN THERAPY | 1 0.01 3.35 ANTIPLATELET THERAPY | 3 0.03 3.38 ANTITUSSIVE THERAPY | 3 0.03 3.41 ANTIVIRAL PROPHYLAXIS | 4 0.04 3.45 ANTIVIRAL TREATMENT | 2 0.02 3.47 ANXIETY | 72 0.72 4.19 ANXIETY DISORDER | 1 0.01 4.20 ANXIOLYTIC THERAPY | 1 0.01 4.21 AORTIC VALVE REPLACEMENT | 5 0.05 4.26 APLASTIC ANAEMIA | 17 0.17 4.43 AREFLEXIA | 1 0.01 4.44 ARRHYTHMIA | 11 0.11 4.55 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 4.56 ARTERIOGRAM CORONARY | 1 0.01 4.57 ARTHRALGIA | 15 0.15 4.72 ARTHRITIS | 34 0.34 5.06 ASPERGILLOSIS | 3 0.03 5.09 ASTHENIA | 7 0.07 5.16 ASTHMA | 48 0.48 5.64 ASTROCYTOMA, LOW GRADE | 1 0.01 5.65 ATRIAL FIBRILLATION | 49 0.49 6.14 ATRIAL FLUTTER | 1 0.01 6.15 ATRIAL TACHYCARDIA | 1 0.01 6.16 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 8 0.08 6.24 AUTISM | 2 0.02 6.26 AUTOIMMUNE DISORDER | 1 0.01 6.27 AUTOIMMUNE HEPATITIS | 4 0.04 6.31 AUTOIMMUNE THYROIDITIS | 2 0.02 6.33 AUTONOMIC NEUROPATHY | 1 0.01 6.34 B-CELL LYMPHOMA | 12 0.12 6.46 BACK PAIN | 35 0.35 6.81 BACTERIAL INFECTION | 9 0.09 6.90 BALANCE DISORDER | 1 0.01 6.91 BASAL CELL CARCINOMA | 1 0.01 6.92 BENIGN PROSTATIC HYPERPLASIA | 3 0.03 6.95 BILE DUCT CANCER | 3 0.03 6.98 BIPOLAR DISORDER | 12 0.12 7.10 BIPOLAR I DISORDER | 4 0.04 7.14 BIPOLAR II DISORDER | 4 0.04 7.18 BLADDER CANCER | 3 0.03 7.21 BLADDER DISORDER | 3 0.03 7.24 BLADDER PAIN | 1 0.01 7.25 BLADDER SPASM | 1 0.01 7.26 BLOOD ANTIDIURETIC HORMONE DECREASED | 3 0.03 7.29 BLOOD CHOLESTEROL | 39 0.39 7.68 BLOOD CHOLESTEROL ABNORMAL | 9 0.09 7.77 BLOOD CHOLESTEROL INCREASED | 119 1.19 8.96 BLOOD CORTICOTROPHIN DECREASED | 4 0.04 9.00 BLOOD CORTISOL DECREASED | 1 0.01 9.01 BLOOD DISORDER | 1 0.01 9.02 BLOOD FOLLICLE STIMULATING HORMONE DE.. | 4 0.04 9.06 BLOOD GLUCOSE | 2 0.02 9.08 BLOOD GLUCOSE ABNORMAL | 3 0.03 9.11 BLOOD GLUCOSE INCREASED | 1 0.01 9.12 BLOOD LUTEINISING HORMONE DECREASED | 4 0.04 9.16 BLOOD PRESSURE | 45 0.45 9.61 BLOOD PRESSURE ABNORMAL | 10 0.10 9.71 BLOOD PRESSURE DECREASED | 1 0.01 9.72 BLOOD PRESSURE INCREASED | 3 0.03 9.75 BLOOD PRESSURE MANAGEMENT | 3 0.03 9.78 BLOOD TESTOSTERONE DECREASED | 733 7.33 17.11 BLOOD TESTOSTERONE FREE DECREASED | 1 0.01 17.12 BLOOD THYROID STIMULATING HORMONE DEC.. | 4 0.04 17.16 BLOOD TRIGLYCERIDES | 1 0.01 17.17 BLOOD TRIGLYCERIDES INCREASED | 8 0.08 17.25 BLOOD URIC ACID INCREASED | 1 0.01 17.26 BONE DENSITY DECREASED | 2 0.02 17.28 BONE DISORDER | 9 0.09 17.37 BONE GIANT CELL TUMOUR | 1 0.01 17.38 BONE MARROW CONDITIONING REGIMEN | 21 0.21 17.59 BONE PAIN | 5 0.05 17.64 BORDERLINE PERSONALITY DISORDER | 2 0.02 17.66 BOWEL MOVEMENT IRREGULARITY | 1 0.01 17.67 BOWEL PREPARATION | 1 0.01 17.68 BRACHYTHERAPY TO PROSTATE | 1 0.01 17.69 BRAIN INJURY | 1 0.01 17.70 BREAKTHROUGH PAIN | 4 0.04 17.74 BREAST CANCER | 80 0.80 18.54 BREAST CANCER METASTATIC | 18 0.18 18.72 BRONCHIAL CARCINOMA | 1 0.01 18.73 BRONCHITIS | 9 0.09 18.82 BRONCHOPNEUMONIA | 5 0.05 18.87 BRONCHOPULMONARY ASPERGILLOSIS | 10 0.10 18.97 BRONCHOPULMONARY DYSPLASIA | 2 0.02 18.99 BRONCHOSPASM | 1 0.01 19.00 BURKITT'S LYMPHOMA | 27 0.27 19.27 BURNING SENSATION | 2 0.02 19.29 BURNOUT SYNDROME | 1 0.01 19.30 BURSITIS | 2 0.02 19.32 CACHEXIA | 1 0.01 19.33 CALCIUM DEFICIENCY | 1 0.01 19.34 CALCIUM METABOLISM DISORDER | 1 0.01 19.35 CANCER PAIN | 7 0.07 19.42 CANDIDIASIS | 2 0.02 19.44 CARCINOID SYNDROME | 2 0.02 19.46 CARCINOID TUMOUR | 11 0.11 19.57 CARDIAC ARREST | 1 0.01 19.58 CARDIAC DISORDER | 41 0.41 19.99 CARDIAC FAILURE | 15 0.15 20.14 CARDIAC FAILURE CHRONIC | 16 0.16 20.30 CARDIAC FAILURE CONGESTIVE | 5 0.05 20.35 CARDIAC HYPERTROPHY | 1 0.01 20.36 CARDIOVASCULAR DISORDER | 6 0.06 20.42 CARDIOVASCULAR EVENT PROPHYLAXIS | 11 0.11 20.53 CAROTID ARTERIOSCLEROSIS | 1 0.01 20.54 CAROTID ARTERY DISEASE | 1 0.01 20.55 CARTILAGE INJURY | 1 0.01 20.56 CATARACT | 1 0.01 20.57 CATHETER PLACEMENT | 1 0.01 20.58 CATHETERISATION CARDIAC | 2 0.02 20.60 CELLULITIS | 1 0.01 20.61 CEREBRAL INFARCTION | 4 0.04 20.65 CEREBROVASCULAR ACCIDENT | 1 0.01 20.66 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 8 0.08 20.74 CHELATION THERAPY | 1 0.01 20.75 CHEMOTHERAPY | 2 0.02 20.77 CHEST PAIN | 3 0.03 20.80 CHOLANGITIS | 1 0.01 20.81 CHOLANGITIS SCLEROSING | 1 0.01 20.82 CHOLELITHIASIS | 1 0.01 20.83 CHOLESTEROSIS | 1 0.01 20.84 CHONDROPATHY | 1 0.01 20.85 CHRONIC LYMPHOCYTIC LEUKAEMIA | 8 0.08 20.93 CHRONIC MYELOID LEUKAEMIA | 49 0.49 21.42 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 35 0.35 21.77 CHRONIC RECURRENT MULTIFOCAL OSTEOMYE.. | 1 0.01 21.78 CLOSTRIDIAL INFECTION | 2 0.02 21.80 COAGULOPATHY | 2 0.02 21.82 COLD AGGLUTININS | 1 0.01 21.83 COLD TYPE HAEMOLYTIC ANAEMIA | 1 0.01 21.84 COLITIS | 3 0.03 21.87 COLITIS ULCERATIVE | 15 0.15 22.02 COLON CANCER | 14 0.14 22.16 COLONOSCOPY | 1 0.01 22.17 COLONY STIMULATING FACTOR THERAPY | 2 0.02 22.19 COLORECTAL CANCER | 22 0.22 22.41 COLORECTAL CANCER METASTATIC | 5 0.05 22.46 COLORECTAL CANCER RECURRENT | 4 0.04 22.50 COMPLEX REGIONAL PAIN SYNDROME | 2 0.02 22.52 COMPUTERISED TOMOGRAM | 3 0.03 22.55 CONSTIPATION | 24 0.24 22.79 CONSTIPATION PROPHYLAXIS | 2 0.02 22.81 CONTINUOUS POSITIVE AIRWAY PRESSURE | 1 0.01 22.82 CONTRACEPTION | 82 0.82 23.64 CONTUSION | 2 0.02 23.66 CONVULSION | 21 0.21 23.87 CONVULSION PROPHYLAXIS | 2 0.02 23.89 CORD BLOOD TRANSPLANT THERAPY | 4 0.04 23.93 CORONARY ARTERIAL STENT INSERTION | 1 0.01 23.94 CORONARY ARTERY BYPASS | 2 0.02 23.96 CORONARY ARTERY DISEASE | 18 0.18 24.14 COUGH | 7 0.07 24.21 CRANIAL NERVE DISORDER | 4 0.04 24.25 CREST SYNDROME | 2 0.02 24.27 CROHN'S DISEASE | 68 0.68 24.95 CUSHING'S SYNDROME | 1 0.01 24.96 CYSTIC FIBROSIS | 2 0.02 24.98 CYSTITIS | 1 0.01 24.99 CYSTITIS INTERSTITIAL | 2 0.02 25.01 CYTOMEGALOVIRUS INFECTION | 1 0.01 25.02 DECREASED APPETITE | 2 0.02 25.04 DEEP VEIN THROMBOSIS | 8 0.08 25.12 DEHYDRATION | 2 0.02 25.14 DELUSION | 1 0.01 25.15 DEMENTIA | 1 0.01 25.16 DEMENTIA ALZHEIMER'S TYPE | 5 0.05 25.21 DEPRESSED MOOD | 2 0.02 25.23 DEPRESSION | 101 1.01 26.24 DERMATOFIBROSARCOMA | 1 0.01 26.25 DEVICE THERAPY | 2 0.02 26.27 DIABETES INSIPIDUS | 1 0.01 26.28 DIABETES MELLITUS | 153 1.53 27.81 DIABETIC NEUROPATHY | 4 0.04 27.85 DIABETIC RETINOPATHY | 3 0.03 27.88 DIABETIC ULCER | 1 0.01 27.89 DIABETIC VASCULAR DISORDER | 1 0.01 27.90 DIAGNOSTIC PROCEDURE | 2 0.02 27.92 DIARRHOEA | 6 0.06 27.98 DIFFUSE LARGE B-CELL LYMPHOMA | 5 0.05 28.03 DISABILITY | 4 0.04 28.07 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 28.08 DISTURBANCE IN ATTENTION | 1 0.01 28.09 DISTURBANCE IN SEXUAL AROUSAL | 1 0.01 28.10 DIURETIC THERAPY | 3 0.03 28.13 DIZZINESS | 2 0.02 28.15 DRUG ABUSE | 2 0.02 28.17 DRUG DEPENDENCE | 6 0.06 28.23 DRUG ERUPTION | 1 0.01 28.24 DRUG WITHDRAWAL SYNDROME | 2 0.02 28.26 DRY EYE | 3 0.03 28.29 DRY SKIN | 1 0.01 28.30 DWARFISM | 1 0.01 28.31 DYSKINESIA | 1 0.01 28.32 DYSLIPIDAEMIA | 4 0.04 28.36 DYSMENORRHOEA | 4 0.04 28.40 DYSPAREUNIA | 1 0.01 28.41 DYSPEPSIA | 12 0.12 28.53 DYSPNOEA | 5 0.05 28.58 DYSTONIA | 1 0.01 28.59 DYSURIA | 1 0.01 28.60 EAR INFECTION | 1 0.01 28.61 ECTOPIC ACTH SYNDROME | 2 0.02 28.63 ECZEMA | 5 0.05 28.68 EMPHYSEMA | 4 0.04 28.72 ENDOCARDITIS PROPHYLAXIS | 1 0.01 28.73 ENDOCRINE NEOPLASM | 1 0.01 28.74 ENDODONTIC PROCEDURE | 1 0.01 28.75 ENDOMETRIOSIS | 3 0.03 28.78 ENTEROBACTER INFECTION | 1 0.01 28.79 ENTEROCOLITIS | 1 0.01 28.80 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 28.81 EOSINOPHILIC PNEUMONIA CHRONIC | 4 0.04 28.85 EPILEPSY | 21 0.21 29.06 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 29.07 ERECTILE DYSFUNCTION | 26 0.26 29.33 ERYSIPELAS | 2 0.02 29.35 ERYTHEMA | 1 0.01 29.36 ESSENTIAL THROMBOCYTHAEMIA | 1 0.01 29.37 EX-TOBACCO USER | 1 0.01 29.38 EXPOSURE VIA FATHER | 2 0.02 29.40 EXPOSURE VIA PARTNER | 1 0.01 29.41 EXTRASYSTOLES | 1 0.01 29.42 EYE DISORDER | 1 0.01 29.43 EYE INFECTION | 1 0.01 29.44 FALLOPIAN TUBE CANCER METASTATIC | 1 0.01 29.45 FATIGUE | 11 0.11 29.56 FEBRILE NEUTROPENIA | 4 0.04 29.60 FIBROMYALGIA | 36 0.36 29.96 FISTULA | 1 0.01 29.97 FLATULENCE | 1 0.01 29.98 FLUID IMBALANCE | 1 0.01 29.99 FLUID OVERLOAD | 1 0.01 30.00 FLUID RETENTION | 9 0.09 30.09 FOETAL EXPOSURE DURING PREGNANCY | 29 0.29 30.38 FOLATE DEFICIENCY | 2 0.02 30.40 FOLLICULITIS | 2 0.02 30.42 FUNGAL INFECTION | 2 0.02 30.44 FUNGAL RHINITIS | 1 0.01 30.45 FURUNCLE | 1 0.01 30.46 GAIT DISTURBANCE | 3 0.03 30.49 GASTRIC CANCER | 11 0.11 30.60 GASTRIC DISORDER | 11 0.11 30.71 GASTRIC ULCER | 4 0.04 30.75 GASTRINOMA | 3 0.03 30.78 GASTRITIS | 6 0.06 30.84 GASTRITIS EROSIVE | 1 0.01 30.85 GASTRITIS PROPHYLAXIS | 3 0.03 30.88 GASTROINTESTINAL ANGIODYSPLASIA | 1 0.01 30.89 GASTROINTESTINAL CARCINOMA | 1 0.01 30.90 GASTROINTESTINAL INFECTION | 1 0.01 30.91 GASTROINTESTINAL PAIN | 1 0.01 30.92 GASTROINTESTINAL STROMAL TUMOUR | 11 0.11 31.03 GASTROOESOPHAGEAL REFLUX DISEASE | 81 0.81 31.84 GAUCHER'S DISEASE | 1 0.01 31.85 GENERAL SYMPTOM | 1 0.01 31.86 GENITAL HERPES | 1 0.01 31.87 GENITALIA EXTERNAL AMBIGUOUS | 1 0.01 31.88 GLAUCOMA | 24 0.24 32.12 GLIOMA | 12 0.12 32.24 GLYCOGEN STORAGE DISEASE TYPE II | 2 0.02 32.26 GOUT | 9 0.09 32.35 GRAFT VERSUS HOST DISEASE | 2 0.02 32.37 GRANULOCYTES ABNORMAL | 1 0.01 32.38 GROWTH HORMONE DEFICIENCY | 4 0.04 32.42 GUTTATE PSORIASIS | 1 0.01 32.43 HAEMOCHROMATOSIS | 1 0.01 32.44 HAEMOGLOBIN DECREASED | 1 0.01 32.45 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 32.47 HAEMOPERFUSION | 1 0.01 32.48 HAEMOPHILIA | 1 0.01 32.49 HAEMORRHAGE PROPHYLAXIS | 1 0.01 32.50 HAEMORRHOIDS | 1 0.01 32.51 HAEMOSTASIS | 4 0.04 32.55 HAIR TRANSPLANT | 1 0.01 32.56 HALLUCINATION | 1 0.01 32.57 HEAD AND NECK CANCER | 2 0.02 32.59 HEADACHE | 25 0.25 32.84 HEART RATE | 1 0.01 32.85 HEART RATE ABNORMAL | 1 0.01 32.86 HEART RATE DECREASED | 1 0.01 32.87 HEART RATE INCREASED | 1 0.01 32.88 HEART RATE IRREGULAR | 3 0.03 32.91 HEART TRANSPLANT | 1 0.01 32.92 HELICOBACTER INFECTION | 3 0.03 32.95 HEPATIC CIRRHOSIS | 1 0.01 32.96 HEPATIC NEOPLASM MALIGNANT | 7 0.07 33.03 HEPATITIS B | 5 0.05 33.08 HEPATITIS C | 89 0.89 33.97 HEREDITARY ANGIOEDEMA | 3 0.03 34.00 HERPES VIRUS INFECTION | 1 0.01 34.01 HERPES ZOSTER | 3 0.03 34.04 HIATUS HERNIA | 2 0.02 34.06 HICCUPS | 2 0.02 34.08 HIDRADENITIS | 1 0.01 34.09 HIP ARTHROPLASTY | 2 0.02 34.11 HIP SURGERY | 4 0.04 34.15 HIRSUTISM | 2 0.02 34.17 HIV INFECTION | 43 0.43 34.60 HIV TEST POSITIVE | 6 0.06 34.66 HODGKIN'S DISEASE | 26 0.26 34.92 HORMONE REPLACEMENT THERAPY | 17 0.17 35.09 HOT FLUSH | 4 0.04 35.13 HUNTINGTON'S DISEASE | 1 0.01 35.14 HYPERCALCAEMIA | 2 0.02 35.16 HYPERCALCAEMIA OF MALIGNANCY | 4 0.04 35.20 HYPERCHLORHYDRIA | 1 0.01 35.21 HYPERCHOLESTEROLAEMIA | 16 0.16 35.37 HYPERGLYCAEMIA | 2 0.02 35.39 HYPERHOMOCYSTEINAEMIA | 4 0.04 35.43 HYPERLIPIDAEMIA | 16 0.16 35.59 HYPERPARATHYROIDISM SECONDARY | 1 0.01 35.60 HYPERPHOSPHATAEMIA | 2 0.02 35.62 HYPERSENSITIVITY | 28 0.28 35.90 HYPERSOMNIA | 1 0.01 35.91 HYPERTENSION | 373 3.73 39.64 HYPERTHYROIDISM | 4 0.04 39.68 HYPERTONIC BLADDER | 3 0.03 39.71 HYPERTRICHOSIS | 1 0.01 39.72 HYPERTRIGLYCERIDAEMIA | 1 0.01 39.73 HYPERURICAEMIA | 5 0.05 39.78 HYPOAESTHESIA | 2 0.02 39.80 HYPOALBUMINAEMIA | 1 0.01 39.81 HYPOGAMMAGLOBULINAEMIA | 1 0.01 39.82 HYPOGONADISM | 12 0.12 39.94 HYPOKALAEMIA | 2 0.02 39.96 HYPOMAGNESAEMIA | 2 0.02 39.98 HYPOMANIA | 6 0.06 40.04 HYPONATRAEMIA | 2 0.02 40.06 HYPOPHARYNGEAL CANCER STAGE II | 1 0.01 40.07 HYPOPITUITARISM | 3 0.03 40.10 HYPOTENSION | 3 0.03 40.13 HYPOTHALAMO-PITUITARY DISORDER | 1 0.01 40.14 HYPOTHYROIDISM | 48 0.48 40.62 HYPOVITAMINOSIS | 2 0.02 40.64 HYSTERECTOMY | 3 0.03 40.67 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 40.68 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 3 0.03 40.71 ILEUS | 1 0.01 40.72 ILL-DEFINED DISORDER | 6 0.06 40.78 IMAGING PROCEDURE | 5 0.05 40.83 IMMUNE SYSTEM DISORDER | 1 0.01 40.84 IMMUNISATION | 1 0.01 40.85 IMMUNOMODULATORY THERAPY | 7 0.07 40.92 IMMUNOSUPPRESSANT DRUG THERAPY | 3 0.03 40.95 IMMUNOSUPPRESSION | 1 0.01 40.96 INDUCTION OF ANAESTHESIA | 5 0.05 41.01 INFANTILE SPASMS | 3 0.03 41.04 INFECTION | 4 0.04 41.08 INFECTION PROPHYLAXIS | 27 0.27 41.35 INFLAMMATION | 2 0.02 41.37 INFLAMMATORY BOWEL DISEASE | 4 0.04 41.41 INFLUENZA | 2 0.02 41.43 INFUSION RELATED REACTION | 1 0.01 41.44 INITIAL INSOMNIA | 1 0.01 41.45 INSOMNIA | 44 0.44 41.89 INTENTIONAL OVERDOSE | 4 0.04 41.93 INTENTIONAL SELF-INJURY | 1 0.01 41.94 INTERSTITIAL LUNG DISEASE | 2 0.02 41.96 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 41.98 INTERVERTEBRAL DISC DISORDER | 1 0.01 41.99 INTERVERTEBRAL DISC PROTRUSION | 1 0.01 42.00 INTRACRANIAL PRESSURE INCREASED | 1 0.01 42.01 INTRAOCULAR PRESSURE INCREASED | 3 0.03 42.04 IRITIS | 1 0.01 42.05 IRON DEFICIENCY | 2 0.02 42.07 IRON METABOLISM DISORDER | 4 0.04 42.11 IRON OVERLOAD | 14 0.14 42.25 IRRITABILITY | 2 0.02 42.27 IRRITABLE BOWEL SYNDROME | 3 0.03 42.30 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 42.31 ISCHAEMIC STROKE | 1 0.01 42.32 JOINT ARTHROPLASTY | 2 0.02 42.34 JOINT INJURY | 2 0.02 42.36 JOINT RANGE OF MOTION DECREASED | 2 0.02 42.38 JUVENILE ARTHRITIS | 30 0.30 42.68 JUVENILE CHRONIC MYELOMONOCYTIC LEUKA.. | 1 0.01 42.69 KAWASAKI'S DISEASE | 2 0.02 42.71 KLEBSIELLA INFECTION | 6 0.06 42.77 KNEE ARTHROPLASTY | 15 0.15 42.92 KNEE OPERATION | 1 0.01 42.93 LABOUR INDUCTION | 1 0.01 42.94 LACRIMATION INCREASED | 1 0.01 42.95 LARYNGITIS | 2 0.02 42.97 LEFT VENTRICULAR FAILURE | 1 0.01 42.98 LEUKOERYTHROBLASTIC ANAEMIA | 1 0.01 42.99 LEUKOPENIA | 1 0.01 43.00 LIBIDO DECREASED | 6 0.06 43.06 LIBIDO DISORDER | 3 0.03 43.09 LICHEN PLANUS | 1 0.01 43.10 LIGAMENT PAIN | 1 0.01 43.11 LIPID METABOLISM DISORDER | 3 0.03 43.14 LIPIDS INCREASED | 1 0.01 43.15 LIPODYSTROPHY ACQUIRED | 2 0.02 43.17 LIVER TRANSPLANT | 2 0.02 43.19 LOCAL ANAESTHESIA | 1 0.01 43.20 LOSS OF LIBIDO | 4 0.04 43.24 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 43.26 LOWER LIMB FRACTURE | 4 0.04 43.30 LUMBAR SPINAL STENOSIS | 1 0.01 43.31 LUNG ADENOCARCINOMA | 3 0.03 43.34 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 7 0.07 43.41 LUNG DISORDER | 1 0.01 43.42 LUNG NEOPLASM MALIGNANT | 10 0.10 43.52 LUNG TRANSPLANT | 6 0.06 43.58 LUPUS NEPHRITIS | 1 0.01 43.59 LYMPHOMA | 3 0.03 43.62 MACULOPATHY | 1 0.01 43.63 MAJOR DEPRESSION | 11 0.11 43.74 MALABSORPTION | 1 0.01 43.75 MALAISE | 3 0.03 43.78 MALIGNANT MELANOMA | 12 0.12 43.90 MALIGNANT SOFT TISSUE NEOPLASM | 1 0.01 43.91 MALNUTRITION | 3 0.03 43.94 MANIA | 7 0.07 44.01 MANTLE CELL LYMPHOMA | 1 0.01 44.02 MASS | 2 0.02 44.04 MATERNAL EXPOSURE DURING PREGNANCY | 31 0.31 44.35 MATERNAL EXPOSURE TIMING UNSPECIFIED | 1 0.01 44.36 MEDICAL DIET | 9 0.09 44.45 MEDICATION DILUTION | 1 0.01 44.46 MEIGE'S SYNDROME | 1 0.01 44.47 MEMORY IMPAIRMENT | 3 0.03 44.50 MENIERE'S DISEASE | 3 0.03 44.53 MENINGITIS | 2 0.02 44.55 MENOPAUSAL SYMPTOMS | 5 0.05 44.60 MENOPAUSE | 3 0.03 44.63 MENORRHAGIA | 9 0.09 44.72 MENSTRUAL CYCLE MANAGEMENT | 1 0.01 44.73 MENSTRUAL DISORDER | 2 0.02 44.75 MENSTRUATION IRREGULAR | 1 0.01 44.76 MENTAL DISORDER | 2 0.02 44.78 METASTASES TO BONE | 9 0.09 44.87 METASTASES TO LIVER | 5 0.05 44.92 METASTASES TO LUNG | 4 0.04 44.96 METASTASES TO SPINE | 1 0.01 44.97 METASTATIC BRONCHIAL CARCINOMA | 1 0.01 44.98 METASTATIC CARCINOID TUMOUR | 5 0.05 45.03 METASTATIC MALIGNANT MELANOMA | 3 0.03 45.06 METASTATIC PAIN | 1 0.01 45.07 METASTATIC RENAL CELL CARCINOMA | 16 0.16 45.23 MICTURITION DISORDER | 1 0.01 45.24 MIDDLE EAR EFFUSION | 1 0.01 45.25 MIGRAINE | 13 0.13 45.38 MIGRAINE PROPHYLAXIS | 1 0.01 45.39 MINERAL SUPPLEMENTATION | 11 0.11 45.50 MITRAL VALVE PROLAPSE | 1 0.01 45.51 MIXED CONNECTIVE TISSUE DISEASE | 1 0.01 45.52 MOOD ALTERED | 2 0.02 45.54 MOOD SWINGS | 2 0.02 45.56 MUCOPOLYSACCHARIDOSIS II | 1 0.01 45.57 MUCOPOLYSACCHARIDOSIS VI | 3 0.03 45.60 MULTIPLE ALLERGIES | 5 0.05 45.65 MULTIPLE DRUG OVERDOSE INTENTIONAL | 3 0.03 45.68 MULTIPLE MYELOMA | 99 0.99 46.67 MULTIPLE SCLEROSIS | 299 2.99 49.66 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 49.67 MUSCLE DISORDER | 1 0.01 49.68 MUSCLE RELAXANT THERAPY | 3 0.03 49.71 MUSCLE SPASMS | 16 0.16 49.87 MUSCLE SPASTICITY | 2 0.02 49.89 MUSCULAR WEAKNESS | 1 0.01 49.90 MUSCULOSKELETAL PAIN | 7 0.07 49.97 MUSCULOSKELETAL STIFFNESS | 2 0.02 49.99 MYALGIA | 4 0.04 50.03 MYASTHENIA GRAVIS | 3 0.03 50.06 MYELODYSPLASTIC SYNDROME | 9 0.09 50.15 MYELOMA RECURRENCE | 4 0.04 50.19 MYOCARDIAL INFARCTION | 5 0.05 50.24 MYOCARDIAL ISCHAEMIA | 8 0.08 50.32 NARCOLEPSY | 5 0.05 50.37 NASAL CONGESTION | 2 0.02 50.39 NASAL DISORDER | 1 0.01 50.40 NAUSEA | 17 0.17 50.57 NECK PAIN | 3 0.03 50.60 NEOPLASM | 1 0.01 50.61 NEOPLASM MALIGNANT | 2 0.02 50.63 NERVE INJURY | 1 0.01 50.64 NERVOUS SYSTEM DISORDER | 2 0.02 50.66 NERVOUSNESS | 3 0.03 50.69 NEURALGIA | 11 0.11 50.80 NEUROBLASTOMA RECURRENT | 2 0.02 50.82 NEURODEGENERATIVE DISORDER | 1 0.01 50.83 NEUROENDOCRINE CARCINOMA | 1 0.01 50.84 NEUROENDOCRINE TUMOUR | 12 0.12 50.96 NEUROGENIC BLADDER | 3 0.03 50.99 NEUROLEPTIC MALIGNANT SYNDROME | 1 0.01 51.00 NEUROPATHY PERIPHERAL | 15 0.15 51.15 NEUROTRANSMITTER LEVEL ALTERED | 2 0.02 51.17 NEUTROPENIA | 5 0.05 51.22 NEUTROPHIL COUNT DECREASED | 3 0.03 51.25 NICOTINE DEPENDENCE | 1 0.01 51.26 NIGHT SWEATS | 2 0.02 51.28 NOCTURIA | 1 0.01 51.29 NON-HODGKIN'S LYMPHOMA | 20 0.20 51.49 NON-SMALL CELL LUNG CANCER | 28 0.28 51.77 NON-SMALL CELL LUNG CANCER STAGE IV | 1 0.01 51.78 NUCHAL RIGIDITY | 1 0.01 51.79 NUCLEAR MAGNETIC RESONANCE IMAGING | 10 0.10 51.89 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 2 0.02 51.91 NUTRITIONAL SUPPORT | 2 0.02 51.93 OBESITY | 3 0.03 51.96 OBSESSIVE-COMPULSIVE DISORDER | 4 0.04 52.00 OCULAR HYPERTENSION | 1 0.01 52.01 OEDEMA | 4 0.04 52.05 OEDEMA PERIPHERAL | 2 0.02 52.07 OESOPHAGEAL SPASM | 1 0.01 52.08 OFF LABEL USE | 8 0.08 52.16 ONCHOCERCIASIS | 8 0.08 52.24 OPTIC NEUROPATHY | 1 0.01 52.25 ORAL CONTRACEPTION | 3 0.03 52.28 ORAL HERPES | 2 0.02 52.30 ORCHIDECTOMY | 1 0.01 52.31 ORGANISING PNEUMONIA | 1 0.01 52.32 OROPHARYNGEAL PAIN | 1 0.01 52.33 ORTHOPEDIC PROCEDURE | 2 0.02 52.35 ORTHOSTATIC HYPOTENSION | 1 0.01 52.36 OSTEITIS DEFORMANS | 1 0.01 52.37 OSTEOARTHRITIS | 17 0.17 52.54 OSTEOGENESIS IMPERFECTA | 1 0.01 52.55 OSTEOMYELITIS | 1 0.01 52.56 OSTEOPENIA | 63 0.63 53.19 OSTEOPOROSIS | 162 1.62 54.81 OSTEOPOROSIS POSTMENOPAUSAL | 5 0.05 54.86 OSTEOPOROSIS PROPHYLAXIS | 7 0.07 54.93 OTITIS MEDIA | 1 0.01 54.94 OVARIAN CYST | 1 0.01 54.95 OVARIAN DISORDER | 1 0.01 54.96 OVARIAN HYPERSTIMULATION SYNDROME | 1 0.01 54.97 OVERDOSE | 1 0.01 54.98 OVERWEIGHT | 1 0.01 54.99 PAIN | 165 1.65 56.64 PAIN IN EXTREMITY | 3 0.03 56.67 PAIN MANAGEMENT | 1 0.01 56.68 PALINDROMIC RHEUMATISM | 1 0.01 56.69 PANCREATIC CARCINOMA | 6 0.06 56.75 PANCREATIC DISORDER | 1 0.01 56.76 PANCREATIC INSUFFICIENCY | 2 0.02 56.78 PANCREATIC NEUROENDOCRINE TUMOUR | 4 0.04 56.82 PANCREATIC NEUROENDOCRINE TUMOUR META.. | 1 0.01 56.83 PANCREATITIS CHRONIC | 2 0.02 56.85 PANIC ATTACK | 3 0.03 56.88 PANIC DISORDER | 2 0.02 56.90 PARKINSON'S DISEASE | 9 0.09 56.99 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 3 0.03 57.02 PARTIAL SEIZURES | 1 0.01 57.03 PENIS DISORDER | 1 0.01 57.04 PEPTIC ULCER | 3 0.03 57.07 PERCUTANEOUS CORONARY INTERVENTION | 1 0.01 57.08 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 57.09 PERITONEAL DIALYSIS | 50 0.50 57.59 PERITONEAL MESOTHELIOMA MALIGNANT | 2 0.02 57.61 PHARYNGITIS | 1 0.01 57.62 PITUITARY TUMOUR BENIGN | 1 0.01 57.63 PITUITARY TUMOUR REMOVAL | 2 0.02 57.65 PLANTAR FASCIITIS | 1 0.01 57.66 PLATELET AGGREGATION ABNORMAL | 3 0.03 57.69 PLATELET COUNT ABNORMAL | 1 0.01 57.70 PLATELET COUNT DECREASED | 1 0.01 57.71 PNEUMONIA | 15 0.15 57.86 PNEUMONIA ASPIRATION | 2 0.02 57.88 PNEUMONIA BACTERIAL | 4 0.04 57.92 PNEUMONIA STAPHYLOCOCCAL | 4 0.04 57.96 POLLAKIURIA | 2 0.02 57.98 POLYARTHRITIS | 3 0.03 58.01 POLYCHONDRITIS | 1 0.01 58.02 POLYCYSTIC OVARIES | 2 0.02 58.04 POLYCYTHAEMIA VERA | 2 0.02 58.06 POLYMYALGIA RHEUMATICA | 1 0.01 58.07 POLYNEUROPATHY | 1 0.01 58.08 POLYURIA | 1 0.01 58.09 POST COITAL CONTRACEPTION | 38 0.38 58.47 POST HERPETIC NEURALGIA | 1 0.01 58.48 POST PROCEDURAL HAEMORRHAGE | 1 0.01 58.49 POST PROCEDURAL OEDEMA | 1 0.01 58.50 POST STROKE DEPRESSION | 1 0.01 58.51 POST-TRAUMATIC STRESS DISORDER | 2 0.02 58.53 POSTINFARCTION ANGINA | 1 0.01 58.54 POSTMENOPAUSE | 3 0.03 58.57 POSTOPERATIVE WOUND INFECTION | 1 0.01 58.58 PRADER-WILLI SYNDROME | 1 0.01 58.59 PRECOCIOUS PUBERTY | 2 0.02 58.61 PREMATURE BABY | 1 0.01 58.62 PREMEDICATION | 24 0.24 58.86 PREMENSTRUAL SYNDROME | 25 0.25 59.11 PREOPERATIVE HORMONE TREATMENT | 1 0.01 59.12 PRIMITIVE NEUROECTODERMAL TUMOUR | 3 0.03 59.15 PROCEDURAL PAIN | 5 0.05 59.20 PROCEDURAL SITE REACTION | 1 0.01 59.21 PRODUCT USED FOR UNKNOWN INDICATION | 1,636 16.36 75.57 PRODUCTIVE COUGH | 4 0.04 75.61 PROLACTINOMA | 1 0.01 75.62 PROPHYLAXIS | 93 0.93 76.55 PROPHYLAXIS AGAINST DIARRHOEA | 1 0.01 76.56 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 16 0.16 76.72 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 18 0.18 76.90 PROPHYLAXIS AGAINST HIV INFECTION | 4 0.04 76.94 PROPHYLAXIS OF NAUSEA AND VOMITING | 6 0.06 77.00 PROSTATE CANCER | 9 0.09 77.09 PROSTATE CANCER METASTATIC | 4 0.04 77.13 PROSTATIC DISORDER | 7 0.07 77.20 PROSTATOMEGALY | 7 0.07 77.27 PROTEINURIA | 1 0.01 77.28 PRURITUS | 5 0.05 77.33 PSEUDOMONAS INFECTION | 1 0.01 77.34 PSORIASIS | 281 2.81 80.15 PSORIATIC ARTHROPATHY | 210 2.10 82.25 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 82.27 PSYCHOTIC DISORDER | 5 0.05 82.32 PULMONARY ARTERIAL HYPERTENSION | 34 0.34 82.66 PULMONARY EMBOLISM | 1 0.01 82.67 PULMONARY HYPERTENSION | 21 0.21 82.88 PULMONARY VENO-OCCLUSIVE DISEASE | 1 0.01 82.89 PUSTULAR PSORIASIS | 1 0.01 82.90 PYREXIA | 15 0.15 83.05 RADICULOPATHY | 1 0.01 83.06 RADIOTHERAPY | 1 0.01 83.07 RASH | 6 0.06 83.13 RAYNAUD'S PHENOMENON | 2 0.02 83.15 RECTAL CANCER | 9 0.09 83.24 RED BLOOD CELL COUNT DECREASED | 1 0.01 83.25 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 19 0.19 83.44 RENAL CANCER | 3 0.03 83.47 RENAL CELL CARCINOMA | 25 0.25 83.72 RENAL DISORDER | 3 0.03 83.75 RENAL FAILURE | 1 0.01 83.76 RENAL FAILURE CHRONIC | 7 0.07 83.83 RENAL IMPAIRMENT | 1 0.01 83.84 RENAL TRANSPLANT | 8 0.08 83.92 RESPIRATORY DISORDER | 1 0.01 83.93 RESPIRATORY DISTRESS | 1 0.01 83.94 RESPIRATORY TRACT CONGESTION | 2 0.02 83.96 RESPIRATORY TRACT INFECTION | 1 0.01 83.97 RESTLESS LEGS SYNDROME | 9 0.09 84.06 RESTLESSNESS | 3 0.03 84.09 RETINAL HAEMORRHAGE | 1 0.01 84.10 RETINAL VEIN OCCLUSION | 2 0.02 84.12 RHEUMATOID ARTHRITIS | 933 9.33 93.45 RHINITIS | 3 0.03 93.48 RHINITIS ALLERGIC | 4 0.04 93.52 RICHTER'S SYNDROME | 5 0.05 93.57 ROSACEA | 3 0.03 93.60 ROUTINE HEALTH MAINTENANCE | 4 0.04 93.64 SACROILIITIS | 1 0.01 93.65 SALIVARY HYPERSECRETION | 2 0.02 93.67 SAPHO SYNDROME | 1 0.01 93.68 SARCOIDOSIS | 3 0.03 93.71 SARCOMA | 2 0.02 93.73 SCHIZOAFFECTIVE DISORDER | 15 0.15 93.88 SCHIZOPHRENIA | 61 0.61 94.49 SCHIZOPHRENIA, PARANOID TYPE | 14 0.14 94.63 SCHIZOPHRENIFORM DISORDER | 1 0.01 94.64 SCIATICA | 4 0.04 94.68 SCLERODERMA | 4 0.04 94.72 SCOLIOSIS | 1 0.01 94.73 SEASONAL ALLERGY | 7 0.07 94.80 SECONDARY HYPOTHYROIDISM | 1 0.01 94.81 SEDATION | 4 0.04 94.85 SELF INJURIOUS BEHAVIOUR | 2 0.02 94.87 SEPSIS | 4 0.04 94.91 SEPTIC ARTHRITIS STAPHYLOCOCCAL | 2 0.02 94.93 SERONEGATIVE ARTHRITIS | 1 0.01 94.94 SERUM FERRITIN INCREASED | 1 0.01 94.95 SEXUAL DYSFUNCTION | 2 0.02 94.97 SICKLE CELL ANAEMIA | 5 0.05 95.02 SINUS CONGESTION | 1 0.01 95.03 SINUS DISORDER | 4 0.04 95.07 SINUS HEADACHE | 2 0.02 95.09 SINUSITIS | 7 0.07 95.16 SINUSITIS FUNGAL | 1 0.01 95.17 SJOGREN'S SYNDROME | 6 0.06 95.23 SKIN COSMETIC PROCEDURE | 3 0.03 95.26 SKIN DISORDER | 1 0.01 95.27 SKIN EXFOLIATION | 1 0.01 95.28 SKIN ULCER | 1 0.01 95.29 SLEEP APNOEA SYNDROME | 2 0.02 95.31 SLEEP DISORDER | 24 0.24 95.55 SLEEP DISORDER THERAPY | 5 0.05 95.60 SLEEP TERROR | 1 0.01 95.61 SMOKING CESSATION THERAPY | 36 0.36 95.97 SPINAL COLUMN STENOSIS | 3 0.03 96.00 SPINAL COMPRESSION FRACTURE | 1 0.01 96.01 SPINAL CORD DISORDER | 2 0.02 96.03 SPINAL DISORDER | 3 0.03 96.06 SPINAL FUSION SURGERY | 1 0.01 96.07 SPINAL OSTEOARTHRITIS | 2 0.02 96.09 SPONDYLITIS | 6 0.06 96.15 SPONDYLOLISTHESIS | 1 0.01 96.16 STAPHYLOCOCCAL BACTERAEMIA | 7 0.07 96.23 STAPHYLOCOCCAL INFECTION | 1 0.01 96.24 STEM CELL TRANSPLANT | 3 0.03 96.27 STENT PLACEMENT | 2 0.02 96.29 STRESS | 1 0.01 96.30 SUBCUTANEOUS ABSCESS | 1 0.01 96.31 SUICIDE ATTEMPT | 1 0.01 96.32 SUPPLEMENTATION THERAPY | 21 0.21 96.53 SUPRAVENTRICULAR EXTRASYSTOLES | 2 0.02 96.55 SURGERY | 1 0.01 96.56 SWELLING | 3 0.03 96.59 SYSTEMIC LUPUS ERYTHEMATOSUS | 5 0.05 96.64 SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE .. | 3 0.03 96.67 SYSTEMIC MYCOSIS | 3 0.03 96.70 TACHYCARDIA | 4 0.04 96.74 TEETHING | 4 0.04 96.78 TENDON PAIN | 1 0.01 96.79 TENDONITIS | 1 0.01 96.80 TESTICULAR DISORDER | 1 0.01 96.81 TESTICULAR FAILURE | 3 0.03 96.84 TESTICULAR TORSION | 1 0.01 96.85 TESTIS CANCER | 2 0.02 96.87 THALASSAEMIA BETA | 1 0.01 96.88 THERAPEUTIC PROCEDURE | 2 0.02 96.90 THROMBOCYTOPENIA | 2 0.02 96.92 THROMBOCYTOSIS | 1 0.01 96.93 THROMBOSIS | 7 0.07 97.00 THROMBOSIS PROPHYLAXIS | 27 0.27 97.27 THROMBOTIC MICROANGIOPATHY | 1 0.01 97.28 THYROID CANCER | 3 0.03 97.31 THYROID DISORDER | 17 0.17 97.48 THYROID FUNCTION TEST ABNORMAL | 2 0.02 97.50 THYROIDECTOMY | 2 0.02 97.52 THYROIDITIS | 1 0.01 97.53 TINEA CRURIS | 1 0.01 97.54 TOBACCO ABUSE | 1 0.01 97.55 TOOTH INFECTION | 1 0.01 97.56 TOOTHACHE | 2 0.02 97.58 TORSADE DE POINTES | 2 0.02 97.60 TOTAL LUNG CAPACITY DECREASED | 1 0.01 97.61 TOURETTE'S DISORDER | 1 0.01 97.62 TRACHEITIS | 2 0.02 97.64 TRANSIENT ISCHAEMIC ATTACK | 3 0.03 97.67 TRANSPLANT | 1 0.01 97.68 TREMOR | 1 0.01 97.69 TUBERCULIN TEST | 2 0.02 97.71 TUBERCULOSIS | 5 0.05 97.76 TUMOUR PAIN | 1 0.01 97.77 TURNER'S SYNDROME | 1 0.01 97.78 TYMPANIC MEMBRANE PERFORATION | 3 0.03 97.81 TYPE 1 DIABETES MELLITUS | 5 0.05 97.86 TYPE 2 DIABETES MELLITUS | 91 0.91 98.77 ULCER | 5 0.05 98.82 ULCER HAEMORRHAGE | 1 0.01 98.83 URGE INCONTINENCE | 2 0.02 98.85 URINARY INCONTINENCE | 8 0.08 98.93 URINARY RETENTION | 1 0.01 98.94 URINARY TRACT DISORDER | 1 0.01 98.95 URINARY TRACT INFECTION | 7 0.07 99.02 URTICARIA | 2 0.02 99.04 UTERINE CONTRACTIONS DURING PREGNANCY | 1 0.01 99.05 UTERINE LEIOMYOMA | 1 0.01 99.06 UTERINE LEIOMYOSARCOMA | 4 0.04 99.10 VAGINAL DISORDER | 1 0.01 99.11 VAGINAL HAEMORRHAGE | 3 0.03 99.14 VASCULITIS | 1 0.01 99.15 VENOUS ULCER PAIN | 1 0.01 99.16 VENTRICULAR EXTRASYSTOLES | 4 0.04 99.20 VERTIGO | 2 0.02 99.22 VITAMIN B COMPLEX DEFICIENCY | 1 0.01 99.23 VITAMIN B1 DEFICIENCY | 2 0.02 99.25 VITAMIN D DECREASED | 5 0.05 99.30 VITAMIN D DEFICIENCY | 2 0.02 99.32 VITAMIN SUPPLEMENTATION | 50 0.50 99.82 VOMITING | 4 0.04 99.86 VON WILLEBRAND'S DISEASE | 1 0.01 99.87 VULVOVAGINAL DRYNESS | 3 0.03 99.90 WEGENER'S GRANULOMATOSIS | 1 0.01 99.91 WEIGHT DECREASED | 2 0.02 99.93 WEIGHT INCREASED | 2 0.02 99.95 WHEEZING | 3 0.03 99.98 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015